Dr. Sarita Kumari is a Senior Consultant and Unit Head in Gynaecologic Surgical Oncology at the Max Institute of Cancer Care, Max Healthcare, New Delhi, India. She completed her medical training (MBBS, MD, DNB, and M.Ch in Gynaecologic Oncology) at the All India Institute of Medical Sciences (AIIMS), New Delhi, and has been awarded numerous honors including international fellowships from the European Society of Gynaecologic Oncology and the Asian Society of Gynaecologic Oncology, the Dr. APJ Abdul Kalam Award for Excellence in Gynaecologic Cancer Care, and multiple research and editorial recognitions. She recently led and contributed to several multicentric clinical and translational research projects, including HPV vaccine trials, AI-driven oncology initiatives, and international collaborative studies in gynecologic cancers. She has published over 100 peer-reviewed papers in various journals and serves as an Editorial Board Member, reviewer, and contributor to multiple international societies and research consortia. Her academic expertise includes gynecologic oncology, surgical oncology, and clinical cancer research, and her research interests include cervical cancer prevention, HPV-related malignancies, fertility preservation, precision oncology, and translational clinical trials.
Dr. Sarita Kumari is a Senior Consultant and Unit Head in Gynaecologic Surgical Oncology at the Max Institute of Cancer Care, Max Healthcare, New Delhi, India. She completed her medical training (MBBS, MD, DNB, and M.Ch in Gynaecologic Oncology) at the All India Institute of Medical Sciences (AIIMS), New Delhi, and has been awarded numerous honors including international fellowships from the European Society of Gynaecologic Oncology and the Asian Society of Gynaecologic Oncology, the Dr. APJ Abdul Kalam Award for Excellence in Gynaecologic Cancer Care, and multiple research and editorial recognitions. She recently led and contributed to several multicentric clinical and translational research projects, including HPV vaccine trials, AI-driven oncology initiatives, and international collaborative studies in gynecologic cancers. She has published over 100 peer-reviewed papers in various journals and serves as an Editorial Board Member, reviewer, and contributor to multiple international societies and research consortia. Her academic expertise includes gynecologic oncology, surgical oncology, and clinical cancer research, and her research interests include cervical cancer prevention, HPV-related malignancies, fertility preservation, precision oncology, and translational clinical trials.